BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16641901)

  • 1. ARF-BP1 as a potential therapeutic target.
    Chen D; Brooks CL; Gu W
    Br J Cancer; 2006 Jun; 94(11):1555-8. PubMed ID: 16641901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
    Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
    Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
    Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
    Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice.
    Kon N; Zhong J; Qiang L; Accili D; Gu W
    J Biol Chem; 2012 Feb; 287(7):5102-11. PubMed ID: 22187431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
    Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
    Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated expression of the ubiquitin protein ligase, E3(Histone)/LASU1/Mule/ARF-BP1/HUWE1, during spermatogenesis.
    Liu Z; Miao D; Xia Q; Hermo L; Wing SS
    Dev Dyn; 2007 Oct; 236(10):2889-98. PubMed ID: 17823942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeostatic defects in B cells deficient in the E3 ubiquitin ligase ARF-BP1 are restored by enhanced expression of MYC.
    Qi CF; Zhang R; Sun J; Li Z; Shin DM; Wang H; Kovalchuk AL; Sakai T; Xiong H; Kon N; Gu W; Morse HC
    Leuk Res; 2013 Dec; 37(12):1680-9. PubMed ID: 24199708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EEL-1 ubiquitin ligase promotes DNA damage-induced germ cell apoptosis in C. elegans.
    Ross AJ; Li M; Yu B; Gao MX; Derry WB
    Cell Death Differ; 2011 Jul; 18(7):1140-9. PubMed ID: 21233842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF.
    Lo D; Zhang Y; Dai MS; Sun XX; Zeng SX; Lu H
    Oncogene; 2015 Mar; 34(13):1688-97. PubMed ID: 24769896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1.
    Zhang X; Berger FG; Yang J; Lu X
    EMBO J; 2011 Jun; 30(11):2177-89. PubMed ID: 21522127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP7S-dependent inactivation of Mule regulates DNA damage signalling and repair.
    Khoronenkova SV; Dianov GL
    Nucleic Acids Res; 2013 Feb; 41(3):1750-6. PubMed ID: 23275561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin ligase ARF-BP1/Mule modulates base excision repair.
    Parsons JL; Tait PS; Finch D; Dianova II; Edelmann MJ; Khoronenkova SV; Kessler BM; Sharma RA; McKenna WG; Dianov GL
    EMBO J; 2009 Oct; 28(20):3207-15. PubMed ID: 19713937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
    Inoue S; Hao Z; Elia AJ; Cescon D; Zhou L; Silvester J; Snow B; Harris IS; Sasaki M; Li WY; Itsumi M; Yamamoto K; Ueda T; Dominguez-Brauer C; Gorrini C; Chio II; Haight J; You-Ten A; McCracken S; Wakeham A; Ghazarian D; Penn LJ; Melino G; Mak TW
    Genes Dev; 2013 May; 27(10):1101-14. PubMed ID: 23699408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
    Wang X; Zha M; Zhao X; Jiang P; Du W; Tam AY; Mei Y; Wu M
    Nat Commun; 2013; 4():1551. PubMed ID: 23462994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage.
    Hall JR; Kow E; Nevis KR; Lu CK; Luce KS; Zhong Q; Cook JG
    Mol Biol Cell; 2007 Sep; 18(9):3340-50. PubMed ID: 17567951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life, death, and ubiquitin: taming the mule.
    Shmueli A; Oren M
    Cell; 2005 Jul; 121(7):963-5. PubMed ID: 15989944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis.
    Zhong Q; Gao W; Du F; Wang X
    Cell; 2005 Jul; 121(7):1085-95. PubMed ID: 15989957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein.
    Yoon SY; Lee Y; Kim JH; Chung AS; Joo JH; Kim CN; Kim NS; Choe IS; Kim JW
    Biochem Biophys Res Commun; 2005 Jan; 326(1):7-17. PubMed ID: 15567145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions.
    Wang L; Luk CT; Schroer SA; Smith AM; Li X; Cai EP; Gaisano H; MacDonald PE; Hao Z; Mak TW; Woo M
    Diabetologia; 2014 Sep; 57(9):1889-98. PubMed ID: 24981769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting roles of ubiquitination in the p53 pathway.
    Shan J; Brooks C; Kon N; Li M; Gu W
    Ernst Schering Found Symp Proc; 2008; (1):127-36. PubMed ID: 19202598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.